[HTML][HTML] Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local …

F Na, J Wang, C Li, L Deng, J Xue, Y Lu - Journal of Thoracic Oncology, 2014 - Elsevier
Introduction: The 2-[18F]-Fluorodeoxyglucose (FDG) positron emission tomography
(PET/CT) has become an imaging tool for clinical assessment of tumor, node, metastasis in …

[HTML][HTML] A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of …

HS Park, FC Detterbeck, DC Madoff… - Journal of Thoracic …, 2022 - ncbi.nlm.nih.gov
Background Clinical decision-making for patients with stage I lung cancer is complex. It
involves multiple options [lobectomy, segmentectomy, wedge, stereotactic body …

Deep segmentation networks predict survival of non-small cell lung cancer

S Baek, Y He, BG Allen, JM Buatti, BJ Smith, L Tong… - Scientific reports, 2019 - nature.com
Non-small-cell lung cancer (NSCLC) represents approximately 80–85% of lung cancer
diagnoses and is the leading cause of cancer-related death worldwide. Recent studies …

FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy

P Lovinfosse, ZL Janvary, P Coucke, S Jodogne… - European journal of …, 2016 - Springer
Abstract Introduction With 18 F-FDG PET/CT, tumor uptake intensity and heterogeneity have
been associated with outcome in several cancers. This study aimed at investigating whether …

Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving …

T Pyka, RA Bundschuh, N Andratschke, B Mayer… - Radiation …, 2015 - Springer
Background Textural features in FDG-PET have been shown to provide prognostic
information in a variety of tumor entities. Here we evaluate their predictive value for …

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer

JY Chang, H Liu, P Balter, R Komaki, Z Liao, J Welsh… - Radiation …, 2012 - Springer
Background Stereotactic ablative radiotherapy (SABR) can achieve excellent local control
rates in early-stage non-small cell lung cancer (NSCLC) and has emerged as a standard …

Comparison of the effectiveness of radiofrequency ablation with stereotactic body radiation therapy in inoperable stage I non-small cell lung cancer: a systemic review …

N Bi, K Shedden, X Zheng - International Journal of Radiation Oncology …, 2016 - Elsevier
Purpose To performed a systematic review and pooled analysis to compare clinical
outcomes of stereotactic body radiation therapy (SBRT) and radiofrequency ablation (RFA) …

Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value

Y Satoh, H Onishi, A Nambu, T Araki - Radiology, 2014 - pubs.rsna.org
Purpose To evaluate the prognostic importance and predictive performance of volume-
based parameters of fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography …

Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating …

A Chi, H Chen, S Wen, H Yan, Z Liao - Radiotherapy and Oncology, 2017 - Elsevier
Purpose To assess hypo-fractionated particle beam therapy (PBT)'s efficacy relative to that
of photon stereotactic body radiotherapy (SBRT) for early stage (ES) non-small cell lung …

Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall‐cell lung cancer patients treated with stereotactic body radiotherapy

Q Li, J Kim, Y Balagurunathan, Y Liu, K Latifi… - Medical …, 2017 - Wiley Online Library
Purpose To investigate whether imaging features from pretreatment planning CT scans are
associated with overall survival (OS), recurrence‐free survival (RFS), and loco‐regional …